DAS Srl Exhibits Range of Fully Automated Systems at MEDLAB Middle East 2020
|
By LabMedica International staff writers Posted on 06 Feb 2020 |
|
Illustration
DAS Srl (Lazio, Italy) displayed the AP22 IF BLOT ELITE system and its lineup of standalone instruments at MEDLAB Middle East, one of the world’s major events in the field of medical diagnostics that was held in Dubai World Trade Center and attended by thousands of visitors from over 135 countries.
At this year’s MEDLAB, DAS Srl displayed the AP 22 IF BLOT ELITE fully automated system for ELISA and IFA and BLOT methods which can run two ELISA micro-plates with eight tests on line, 16 IFA slides or 24 BLOT strips. In addition to ELISA and IFA processing (AP22, AP22 IF), it can carry out full automation for the Dot/Western Blot, thanks to the blot module and a camera, starting from sample dilution and dispense, reagent dispense, incubation, strip washing to the dot imaging processing and assessment for each strip.
DAS Srl also exhibited its lineup of standalone instruments, including PLATE READER, an eight channel photometer for sequential and simultaneous reading of micro-plate strips with 96 wells; PLATE WASHER, an automated washer for micro-plates with 96 wells featuring an original and versatile aspirate and dispense system that requires less than 3µl of residue washing liquid; and STRIP READER, a one channel photometer able that can read strips with 8/12 wells or part of them and is a mono and bi-chromatic reading system.
DAS Srl also displayed NEO-BIL Plus, an advanced and innovative version of traditional bilirubinometers for analyzing the 'total bilirubin' through a microcapillary tube without using reagents. It performs precise sample measurement of both bilirubin and interferentials on the same point of the capillary through a special reading system using a small quantity of serum. At MEDLAB 2020, DAS Srl exhibited the HB ANALYZER PLUS, a hemoglobinometer for fast and accurate determination of hemoglobin using the cyanmetahemoglobin method. The HB ANALYZER PLUS immediately displays the direct reading, expressed in concentration (g/l, g/dl, mmol/l).
Related Links:
DAS Srl
At this year’s MEDLAB, DAS Srl displayed the AP 22 IF BLOT ELITE fully automated system for ELISA and IFA and BLOT methods which can run two ELISA micro-plates with eight tests on line, 16 IFA slides or 24 BLOT strips. In addition to ELISA and IFA processing (AP22, AP22 IF), it can carry out full automation for the Dot/Western Blot, thanks to the blot module and a camera, starting from sample dilution and dispense, reagent dispense, incubation, strip washing to the dot imaging processing and assessment for each strip.
DAS Srl also exhibited its lineup of standalone instruments, including PLATE READER, an eight channel photometer for sequential and simultaneous reading of micro-plate strips with 96 wells; PLATE WASHER, an automated washer for micro-plates with 96 wells featuring an original and versatile aspirate and dispense system that requires less than 3µl of residue washing liquid; and STRIP READER, a one channel photometer able that can read strips with 8/12 wells or part of them and is a mono and bi-chromatic reading system.
DAS Srl also displayed NEO-BIL Plus, an advanced and innovative version of traditional bilirubinometers for analyzing the 'total bilirubin' through a microcapillary tube without using reagents. It performs precise sample measurement of both bilirubin and interferentials on the same point of the capillary through a special reading system using a small quantity of serum. At MEDLAB 2020, DAS Srl exhibited the HB ANALYZER PLUS, a hemoglobinometer for fast and accurate determination of hemoglobin using the cyanmetahemoglobin method. The HB ANALYZER PLUS immediately displays the direct reading, expressed in concentration (g/l, g/dl, mmol/l).
Related Links:
DAS Srl
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Electrolyte Analyzer
BKE-B
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Latest MEDLAB 2020 News
- Diagnostica Stago Displays STA Compact Max and STA Satellite Max Analyzers at MEDLAB
- GeneMatrix Promotes Sex and Respiratory Infection Testing Products at MEDLAB
- Mindray Showcases Comprehensive IVD Solutions Portfolio at MEDLAB Middle East 2020
- New Technology that Detects MRSA in 15 Minutes Introduced at MEDLAB Middle East 2020
- Vircell Exhibits Its New VirClia Lotus and qSPEED-OLIGO Systems at MEDLAB
- Randox Showcases New All-In-One Solution for Molecular Diagnostics at MEDLAB Middle East 2020
- EKF Diagnostics Displays POC Analyzers for Hemoglobin, HbA1c And Lactate at MEDLAB Middle East
- Erba Mannheim Launches New Electrolyte Analyzer with Maintenance-free Electrodes at MEDLAB 2020
- MEDLAB Middle East 2020 Addresses Future of Laboratory Medicine
Channels
Clinical Chemistry
view channel
Next Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing
Clinical laboratories continue to face staffing shortages, limited space, and growing test volumes that pressure chemistry and electrolyte workflows. Maintaining rapid turnaround times increasingly depends... Read more
Blood Metabolite Test Detects Early Cognitive Decline
Timely identification of individuals at risk of dementia remains difficult because symptoms commonly appear only after significant neurodegeneration. Accessible screening tools that flag subtle cognitive... Read more
Molecular Diagnostics
view channel
Immune Signatures in Blood Help Inform Cancer Risk in Lynch Syndrome
Lynch syndrome is a hereditary condition that increases risk for colorectal and endometrial cancers and often results in earlier-onset disease. Clinicians need better ways to stratify asymptomatic carriers... Read more
Genetic Marker Predicts Early Heart Failure in Pulmonary Arterial Hypertension
Pulmonary arterial hypertension is a progressive condition characterized by obstructed pulmonary blood flow and strain on the right heart, with half of patients dying within five years of diagnosis.... Read more
Genomic Subtyping Assays Identify High-Risk Early-Stage Breast Cancers
Racial survival disparities in early-stage breast cancer remain a persistent clinical concern in the United States, with Black women experiencing higher mortality despite similar treatments.... Read more
cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample
Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read moreHematology
view channel
Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
Blood cancers encompass diverse entities whose biology and clinical behavior are best understood through integrative analyses across large cohorts. However, multi‑omic datasets and outcomes information... Read more
AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
Bone marrow aspirate examination is central to diagnosing and monitoring blood cancers and other serious hematologic diseases, yet the process in many laboratories remains manual and highly dependent on... Read more
Immunology
view channel
Combined Screening Approach Identifies Early Leprosy Cases
Leprosy remains a significant public health concern, with more than 200,000 new cases reported globally each year and early disease often escaping routine laboratory detection. In its initial phase, bacterial... Read more
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read moreMicrobiology
view channel
New Bacterial Target Identified for Early Detection of Noma
Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read more
Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
Streptococcus dysgalactiae subspecies equisimilis (SDSE) infections are increasing worldwide and include variants that may lead to severe disease. Researchers now report that whole-genome sequencing of... Read more
Pathology
view channel
AI Tool Predicts Chemotherapy Response in Small Cell Lung Cancer
Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more_image.png "Image: Through neoadjuvant therapy combining chemotherapy with immune checkpoint inhibitors (ICI) for 46 LAGC patients and single-cell transcriptome sequencing, researchers found that tumor cells in the treatment-sensitive group specifically upregulated MHC-II (tumor-specific major histocompatibility complex class II, tsMHC-II) molecules (photo courtesy of Science China Press)")
Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer
Gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer mortality worldwide, with China bearing nearly half of the global burden. Only a subset of patients benefit from... Read more
Technology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read more
Industry
view channel
Global Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials
CellCarta and Pillar Biosciences announced a global, multi-year strategic partnership on April 2, 2026 to broaden access to operationally streamlined next-generation sequencing (NGS) tumor profiling for... Read more
